Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prime Medicine (PRME) Other financing activities: 2021-2022

Historic Other financing activities for Prime Medicine (PRME) over the last 1 years, with Dec 2022 value amounting to $1.4 million.

  • Prime Medicine's Other financing activities rose 28.91% to $1.4 million in Q4 2022 from the same period last year, while for Dec 2022 it was $4.0 million, marking a year-over-year change of. This contributed to the annual value of $4.0 million for FY2022, which is 272.19% up from last year.
  • As of Q4 2022, Prime Medicine's Other financing activities stood at $1.4 million, which was up 87.67% from $746,000 recorded in Q3 2022.
  • Prime Medicine's Other financing activities' 5-year high stood at $1.4 million during Q4 2022, with a 5-year trough of $624,000 in Q2 2022.
  • Moreover, its 2-year median value for Other financing activities was $1.1 million (2021), whereas its average is $1.0 million.
  • Data for Prime Medicine's Other financing activities shows a peak YoY rose of 28.91% (in 2022) over the last 5 years.
  • Over the past 2 years, Prime Medicine's Other financing activities (Quarterly) stood at $1.1 million in 2021, then grew by 28.91% to $1.4 million in 2022.
  • Its Other financing activities was $1.4 million in Q4 2022, compared to $746,000 in Q3 2022 and $624,000 in Q2 2022.